Counseling about anti-inflammatory drugs plays role in peptic ulcer disease outcomes, study reveals.
Rollins
G
G
D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use; D003376:Counseling; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000453:epidemiology; D016480:Helicobacter pylori; D006801:Humans; D009316:National Institutes of Health (U.S.); D010043:Outcome and Process Assessment, Health Care; D010353:Patient Education as Topic; D010359:Patient Readmission; D010437:Peptic Ulcer / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D014481:United States
D000894:Anti-Inflammatory Agents, Non-Steroidal